Skip to main content
. Author manuscript; available in PMC: 2012 Jun 28.
Published in final edited form as: JAMA. 2011 Dec 12;306(24):2673–2683. doi: 10.1001/jama.2011.1830

Table 2.

Adjusted rate ratios for serious cardiovascular events, associated with ADHD medication use, remote use comparison

Medication status Person-
yrs
Number
Events
Rate/1,000
person-yrs
Unadjusted
RR
Adjusted
matching
variables
RRa
Adjusted
RRb
95% CI
MI
  Current use 113,324.2 152 1.34 0.64 0.98 1.08 0.86 – 1.36
     Amphetamines 49,080.1 59 1.20 0.57 0.99 1.12 0.83 – 1.52
     Methylphenidate 51,232.8 77 1.50 0.71 1.00 1.10 0.83 – 1.45
     Atomoxetine 8,424.8 11 1.31 0.62 0.99 1.06 0.57 – 1.96
     Pemoline 3,047.3 5 1.64 0.78 0.87 0.87 0.36 – 2.12
     Multiple 1,539.1 0 0.00 -- -- -- --
  Indeterminate use 53,896.7 86 1.60 0.76 1.19 1.31 1.00 – 1.71
  Former use 47,858.5 65 1.36 0.64 0.92 0.96 0.71 – 1.28
  Remote use 69,792.9 147 2.11 1.00 1.00 1.00 reference
SCDc
  Current use 107,525.0 32 0.30 0.41 0.79 0.82 0.52 – 1.29
     Amphetamines 46,910.0 13 0.28 0.38 0.85 0.94 0.51 – 1.76
     Methylphenidate 47,887.1 13 0.27 0.37 0.66 0.68 0.37 – 1.27
     Atomoxetine 8,257.6 4 0.48 0.66 1.14 1.06 0.38 – 2.95
     Pemoline 2,995.7 2 0.67 0.91 1.11 1.10 0.27 – 4.56
     Multiple 1,474.5 0 0.00 -- -- -- --
  Indeterminate use 51,814.0 14 0.27 0.37 0.70 0.74 0.41 – 1.35
  Former use 46,263.5 20 0.43 0.59 0.94 0.92 0.55 – 1.55
  Remote use 68,102.6 50 0.73 1.00 1.00 1.00 reference
Stroked
  Current use 111,935.5 63 0.56 0.58 0.90 0.93 0.65 – 1.31
     Amphetamines 48,672.9 19 0.39 0.40 0.70 0.77 0.46 – 1.29
     Methylphenidate 50,332.3 39 0.77 0.80 1.15 1.15 0.77 – 1.72
     Atomoxetine 8,371.1 3 0.36 0.37 0.55 0.54 0.17 – 1.71
     Pemoline 3,030.1 2 0.66 0.68 0.74 0.72 0.18 – 2.96
     Multiple 1,529.2 0 0.00 -- -- -- --
  Indeterminate use 53,327.8 31 0.58 0.60 0.96 1.01 0.65 – 1.54
  Former use 47,333.0 39 0.82 0.85 1.24 1.23 0.83 – 1.83
  Remote use 69,202.3 67 0.97 1.00 1.00 1.00 reference
MI, SCD or strokec,d
  Current use 107,322.4 234 2.18 0.61 0.96 1.03 0.86 – 1.24
     Amphetamines 46,826.5 88 1.88 0.52 0.93 1.05 0.82 – 1.34
     Methylphenidate 47,792.3 120 2.51 0.70 1.01 1.07 0.86 – 1.34
     Atomoxetine 8,248.2 17 2.06 0.57 0.90 0.92 0.56 – 1.50
     Pemoline 2,985.2 9 3.01 0.84 0.95 0.93 0.48 – 1.82
     Multiple 1,470.1 0 0.00 -- -- -- --
  Indeterminate use 51,709.6 125 2.42 0.67 1.09 1.17 0.94 – 1.45
  Former use 46,120.8 121 2.62 0.73 1.06 1.07 0.86 – 1.33
  Remote use 67,489.0 243 3.60 1.00 1.00 1.00 reference

Abbreviations: MI, myocardial infarction; SCD, sudden cardiac death; RR, rate ratio; CI, confidence interval; CRS, cardiovascular risk score; KP, Kaiser Permanente

a

Adjusted for site, age, sex, and calendar year (ie, matching variables).

b

Adjusted for site, age, sex, calendar year, and CRS (some variables within score are time-varying).

c

Analyses excluded the three HMORN sites (Fallon Community, KP Georgia, KP Northwest) that did not provide data on SCD endpoints.

d

Analyses excluded the two HMORN sites (Fallon Community, KP Georgia) that did not provide data on stroke endpoints.

HHS Vulnerability Disclosure